Heart Failure Care: How Early Transfers Can Impact Recovery
"Discover how Japanese hospitals are using early patient transfers to improve outcomes and manage resources in heart failure treatment."
Heart failure (HF) is a major health challenge worldwide, leading to frequent hospitalizations, increased morbidity and mortality, and significant strain on healthcare systems. In Japan, the situation is becoming critical with a predicted rise in the number of HF patients to 1.3 million by 2030, creating what experts term an 'HF pandemic.' This surge is causing bed shortages in core hospitals that are equipped to handle acute HF cases.
To address these challenges, a new approach is being explored: regional cooperation between core hospitals and collaborating hospitals. Core hospitals begin the acute treatment, and once patients are stabilized, they are transferred to collaborating hospitals for ongoing care. However, questions remain about the safety and effectiveness of transferring patients during the early treatment phase.
A recent study investigated the outcomes of early HF patient transfers from a core hospital to collaborating hospitals in Japan. The study aimed to determine if this approach, when combined with well-defined treatment strategies, could maintain or improve patient prognoses.
From Dropsy to Modern Heart Failure Care
The history of heart failure traces an evolution from ancient healing practices to modern pharmacology and device therapy. In the 17th century, dropsy was treated with methods such as bloodletting, leeching, and lancing before Harvey's descriptions of cardiovascular circulation advanced understanding. Later, Starling's laws of hemodynamics connected end-diastolic volume with cardiac performance, helping establish foundations for contemporary heart failure management.
The Impact of Early Transfer Strategies on Patient Outcomes
The study, published in the International Heart Journal in 2018, focused on 166 patients hospitalized with acute HF between January 1, 2015, and December 31, 2015. Researchers compared two groups: patients transferred early to collaborating hospitals (n = 53, median transfer time of 6 days) and those who remained in the core hospital (n = 113).
- Similar Mortality Rates: The one-year mortality rates were similar between the transferred (24.5%) and non-transferred groups (19.5%).
- No Increased Risk: Multivariate analysis showed that patient transfers were not associated with a higher risk of the composite endpoint (mortality and HF readmission).
- Importance of Congestion Management: Patients with low composite congestion scores (CCSs) at the time of transfer had significantly better outcomes.
Refining Classification and Acute-Care Strategies
Recent heart failure research continues to refine patient classification and treatment strategies. One study classified patients with heart failure with midrange ejection fraction into improved, stable, and deteriorated groups according to their previously documented left ventricular ejection fraction. A 2026 evidence update also highlighted the PUSH-AHF trial, which evaluated guiding decongestive therapy in acute heart failure with volume overload using spot urine sodium.
Expanding Treatment Options
Heart failure management has become increasingly complex as treatment options have expanded across different left ventricular ejection fraction categories. Developments include advances for heart failure with reduced ejection fraction and preserved ejection fraction, along with newer approaches for other patient groups. For severe or medically unresponsive heart failure, implantable cardioverter-defibrillators, cardiac resynchronization therapy, and ventricular assist devices are described as important device-based alternatives.
Strategic Decongestion is Key
The study underscores the importance of strategic decongestion before transferring patients. By ensuring patients are stable and have low congestion scores, hospitals can optimize the benefits of early transfer. This approach not only aids in resource management but also maintains quality of care. Further studies are needed to explore how these strategies can be adapted and implemented in different healthcare systems worldwide to combat the growing heart failure pandemic.
What Early Transfers May Show
Evidence from a study of early transfers of patients with acute heart failure from a core hospital to collaborating hospitals found no association between transfer and a higher composite endpoint. Its multivariate analysis reported a hazard ratio of 1.08, with a 95% confidence interval of 0.58 to 1.99 and P = 0.82. These findings suggest that, in the studied setting, early transfer was not linked to worse prognosis.
Learning From Real-World Care
Real-world heart failure care is difficult to study because complex inpatient interventions require substantial time and expense to evaluate. The Acute Decompensated Heart Failure National Registry, known as ADHERE, is described as an important source of real-world data, but it is nearly 20 years old. Creating ADHERE took four years and tens of millions of dollars, illustrating why regularly updating or replicating large heart failure datasets can be challenging.